Intended Audience
The target audience for the Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) program series is patient care providers and others who wish to learn the basic principles of tumor immunology and immunotherapy, and to improve their ability to integrate immunotherapy into state-of-the-art clinical management for their patients.
This intended audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, allied health professionals, other patient care providers, students and patient advocates.